Neonatal phenylketonuria screening gives 90% ROI in Libya

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.617, 2010-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neonatal screening for metabolic disorders warranted in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Neonatal screening for congenital disorders inadequate?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 486, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Routine screening for prevention of neonatal kernicterus too costly?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Prophylaxis, screening and treatment all have a place in the management of neonatal chlamydial infections

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 4, 2006-04 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite